EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 277-283

  Bastid, Jeremy ^a  

^a OREGA Biotech   (France)

Author keywords

Epithelial to mesenchymal transition; Metastasis; Tumor progression

Indexed keywords

CALVASCULIN; K RAS PROTEIN; UVOMORULIN; VIMENTIN;

BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CELL DIFFERENTIATION; CIRCULATING TUMOR CELL; COLORECTAL TUMOR; DNA CONTENT; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; LUNG NODULE; MALIGNANT TERATOMA; METASTASIS; NONHUMAN; ONCOGENE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR BIOPSY;

CARCINOMA; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASMS;

EID: 84862333338     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9344-6     Document Type: Review

References (53)

1. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117(7), 927-939. (Pubitemid 38798858)
2. Thiery, J. P., Acloque, H., Huang, R. Y., & Nieto, M. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139(5), 871-890.
3. Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9(4), 265-273.
4. Xue, C., Plieth, D., Venkov, C., Xu, C., & Neilson, E. G. (2003). The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Research, 63(12), 3386-3394. (Pubitemid 36735899)
5. Trimboli, A. J., Fukino, K., de Bruin, A., Wei, G., Shen, L., Tanner, S. M., et al. (2008). Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Research, 68(3), 937-945. (Pubitemid 351206773)
6. Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., et al. (2006). A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology, 131(3), 830-840. (Pubitemid 44307069)
7. Prall, F. (2007). Tumour budding in colorectal carcinoma. Histopathology, 50(1), 151-162.
8. Ueno, H., Mochizuki, H., Hashiguchi, Y., Shimazaki, H., Aida, S., Hase, K., et al. (2004). Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology, 127(2), 385-394. (Pubitemid 39091886)
9. Zlobec, I., & Lugli, A. (2010). Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget, 1(7), 651-661.
10. Ansieau, S., Bastid, J., Doreau, A., Morel, A. P., Bouchet, B. P., Thomas, C., et al. (2008). Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell, 14(1), 79-89. (Pubitemid 351890463)
11. Prall, F., & Ostwald, C. (2007). High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations. Human Pathology, 38(11), 1696-1702. (Pubitemid 47589093)
12. Wang, C., Huang, H., Huang, Z., Wang, A., Chen, X., Huang, L., et al. (2011). Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. Journal of Oral Pathology & Medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
13. Aktas, B., Tewes, M., Fehm, T., Hauch, S., Kimmig, R., & Kasimir-Bauer, S. (2009). Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Research, 11(4).
14. Raimondi, C., Gradilone, A., Naso, G., Vincenzi, B., Petracca, A., Nicolazzo, C., et al. (2011). Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Research and Treatment. doi:10.1007/s10549-011-1373-x.
15. Rees, J. R., Onwuegbusi, B. A., Save, V. E., Alderson, D., &Fitzgerald, R. C. (2006). In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Research, 66 (19), 9583-9590. (Pubitemid 44623657)
16. Montserrat, N., Mozos, A., Llobet, D., Dolcet, X., Pons, C., de Herreros, A. G., et al. (2011). Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma. Human Pathology. doi:10.1016/j.humpath.2011. 06.021.
17. van Deurzen, C. H., Lee, A. H., Gill, M. S., Menke-Pluijmers, M. B., Jager, A., Ellis, I. O., et al. (2011). Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation? The Journal of Pathology. doi:10.1002/path.2872.
18. Halachmi, S., DeMarzo, A. M., Chow, N. H., Halachmi, N., Smith, A. E., Linn, J. F., et al. (2000). Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin. European Urology, 37(3), 350-357. (Pubitemid 30122273)
19. Zhuang, Z., Lininger, R. A., Man, Y. G., Albuquerque, A., Merino, M. J., & Tavassoli, F. A. (1997). Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity. Modern Pathology, 10(4), 354-362. (Pubitemid 27228884)
20. Teixeira, M. R., Qvist, H., Bohler, P. J., Pandis, N., & Heim, S. (1998). Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin. Genes, Chromosomes & Cancer, 22(2), 145-151. (Pubitemid 28208807)
21. Fujii, H., Yoshida, M., Gong, Z. X., Matsumoto, T., Hamano, Y., Fukunaga, M., et al. (2000). Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Research, 60(1), 114-120. (Pubitemid 30058740)
22. Tarin, D., Thompson, E. W., & Newgreen, D. F. (2005). The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research, 65(14), 5996-6000. discussion 6000-5991.
23. Sivertsen, S., Hadar, R., Elloul, S., Vintman, L., Bedrossian, C., Reich, R., et al. (2006). Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer, 54 (3), 309-317. (Pubitemid 44740263)
24. Blechschmidt, K., Sassen, S., Schmalfeldt, B., Schuster, T., Hofler, H., & Becker, K. F. (2008). The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. British Journal of Cancer, 98(2), 489-495. (Pubitemid 351161237)
25. Cates, J. M., Byrd, R. H., Fohn, L. E., Tatsas, A. D., Washington, M. K., & Black, C. C. (2009). Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas, 38(1), e1-6. doi:10.1097/MPA. 0b013e3181878b7f.
26. Scheel, C., Eaton, E. N., Li, S. H., Chaffer, C. L., Reinhardt, F., Kah, K. J., et al. (2011). Paracrine and autocrine signals induce andmaintain mesenchymal and stem cell states in the breast. Cell, 145 (6), 926-940.
27. Thiery, J. P., & Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nature Reviews Molecular Cell Biology, 7(2), 131-142. (Pubitemid 43278296)
28. Olmeda, D., Jorda, M., Peinado, H., Fabra, A., & Cano, A. (2007). Snail silencing effectively suppresses tumour growth and invasiveness. [Research Support, Non-U.S. Gov't]. Oncogene, 26(13), 1862-1874. (Pubitemid 46474642)
29. Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006). Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2. Cancer Research, 66(23), 11271-11278. (Pubitemid 46009956)
30. Bonnomet, A., Syne, L., Brysse, A., Feyereisen, E., Thompson, E. W., Noel, A., et al. (2011). A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene. doi:10.1038/onc.2011.540.
31. Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., et al. (2005). Tumour biology: Senescence in premalignant tumours. Nature, 436(7051), 642. (Pubitemid 41117258)
32. Eng, C., Leone, G., Orloff, M. S., & Ostrowski, M. C. (2009). Genomic alterations in tumor stroma. Cancer Research, 69(17), 6759-6764.
33. Gjorevski, N., Boghaert, E., & Nelson, C. M. (2011). Regulation of epithelial-mesenchymal transition by transmission of mechanical stress through epithelial tissues. Cancer Microenvironment: official journal of the International Cancer Microenvironment Society. doi:10.1007/s12307-011-0076-5.
34. Yang, M. H., Wu, M. Z., Chiou, S. H., Chen, P. M., Chang, S. Y., Liu, C. J., et al. (2008). Direct regulation of TWIST by HIF-1alpha promotes metastasis. [Research Support, Non-U.S. Gov't]. Nature Cell Biology, 10(3), 295-305. doi:10.1038/ncb1691.
35. Koo, V., El Mekabaty, A., Hamilton, P., Maxwell, P., Sharaf, O., Diamond, J., et al. (2010). Novel in vitro assays for the characterization of EMT in tumourigenesis. Cellular Oncology, 32(1-2).
36. Guaita, S., Puig, I., Franci, C., Garrido, M., Dominguez, D., Batlle, E., et al. (2002). Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. Journal of Biological Chemistry, 277(42), 39209-39216. (Pubitemid 35190890)
37. Gradilone, A., Raimondi, C., Nicolazzo, C., Petracca, A., Gandini, O., Vincenzi, B., et al. (2011). Circulating tumor cells lacking cytokeratin in breast cancer: The importance of being mesenchymal. Journal of Cellular and Molecular Medicine. doi:10.1111/j.1582-4934.2011.01285.x.
38. Greenburg, G., & Hay, E. D. (1982). Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. The Journal of Cell Biology, 95(1), 333-339. (Pubitemid 13197104)
39. Stoker, M., & Perryman, M. (1985). An epithelial scatter factor released by embryo fibroblasts. Journal ofCell Science, 77, 209-223.
40. Stoker, M., Gherardi, E., Perryman, M., & Gray, J. (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature, 327(6119), 239-242. (Pubitemid 17071053)
41. Maestro, R., Dei Tos, A. P., Hamamori, Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., et al. (1999). Twist is a potential oncogene that inhibits apoptosis. Genes & Development, 13(17), 2207-2217. (Pubitemid 29426726)
42. Cano, A., Perez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., et al. (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biology, 2(2), 76-83.
43. Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J., et al. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biology, 2(2), 84-89.
44. Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nature Reviews. Cancer, 2(6), 442-454.
45. Inoue, A., Seidel, M. G., Wu, W., Kamizono, S., Ferrando, A. A., Bronson, R. T., et al. (2002). Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell, 2(4), 279-288. (Pubitemid 41043962)
46. Kajita, M., McClinic, K. N., & Wade, P. A. (2004). Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Molecular and Cellular Biology, 24 (17), 7559-7566. (Pubitemid 39121483)
47. Wu, W. S., Heinrichs, S., Xu, D., Garrison, S. P., Zambetti, G. P., Adams, J. M., et al. (2005). Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell, 123 (4), 641-653. (Pubitemid 41613746)
48. Knutson, K. L., Lu, H., Stone, B., Reiman, J. M., Behrens, M. D., Prosperi, C. M., et al. (2006). Immunoediting of cancers may lead to epithelial to mesenchymal transition. Journal of Immunology, 177(3), 1526-1533.
49. Peinado, H., Olmeda, D., & Cano, A. (2007). Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nature Reviews. Cancer, 7(6), 415-428. (Pubitemid 46809165)
50. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704-715. (Pubitemid 351636299)
51. Morel, A. P., Lievre, M., Thomas, C., Hinkal, G., Ansieau, S., &Puisieux, A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 3(8), e2888. doi:10.1371/journal. pone.0002888.
52. Chang, C. J., Chao, C. H., Xia, W., Yang, J. Y., Xiong, Y., Li, C. W., et al. (2011). p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nature Cell Biology, 13(3), 317-323.
53. Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., et al. (2009). Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Research, 69(7), 2887-2895.